Renal lesions have repeatedly been described in Wilson's disease (WD).
We investigated the excretion of total protein, albumin, low (LMW) an
d high molecular weight (HMW) proteins, N-acetyl-beta-D-glucosaminidas
e (NAG), and calcium, as well as creatinine clearance, in 24-h urine s
amples of 41 patients with WD aged 6-37 (mean 17) years who had been t
reated for a period of 0-15 (mean 4.5) years with D-penicillamine (900
mg/day). The amount of all protein excreted was significantly increas
ed compared with controls, 39% of patients presenting with total prote
inuria more than two standard deviations from the mean of controls. Th
e changes in protein excretion depended on the duration of treatment.
LMW proteinuria was elevated almost exclusively in the first 2 years a
fter the start of treatment, indicating early tubular damage. This is
supported by an initially high excretion of beta(2)-microglobulin, NAG
, and calcium. Increased excretion of HMW proteins, including albumin,
persisted over longer periods, which suggests glomerular injury in so
me patients, possibly related to the use of D-penicillamine, Creatinin
e clearance remained roughly within normal limits. We propose that ren
al function should regularly be checked in patients with WD.